Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Journal of Clinical Oncology, 05/13/09
Wiegel T et al. - In a study to compare radical prostatectomy (RP) followed by immediate radiotherapy (RT) with RP alone for pts with pT3 prostate cancer (PCa) and an undetectable prostate-specific antigen (PSA) level after RP, it was reported that adjuvant RT for pT3 PCa with postoperatively undetectable PSA significantly reduces the risk of biochemical progression.
Methods- After RP, 192 men were randomly assigned to a wait-and-see policy, and 193 men were assigned to immediate postoperative RT.
- Eligible pts had pT3 pN0 tumors.
- Pts who did not achieve an undetectable PSA after RP were excluded from treatment according to random assignment (n = 78; 20%).
- 34 of 307 pts on the RT arm did not receive RT and 5 pts on the wait-and-see arm received RT.
- 114 pts underwent RT and 154 pts were treated with a wait-and-see policy.
- Primary endpoint was biochemical progression-free survival (PFS).
- Biochemical PFS after 5 yrs in pts with undetectable PSA after RP was significantly improved in the RT group (72% vs 54%).
- On univariate analysis, Gleason score >6 and <7, PSA before RP, tumor stage, and positive surgical margins were predictors of outcome.
- Rate of grade 3 to 4 late adverse effects was 0.3%.
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Surgical Technique...keeping you current
Receive free subspecialty "5-minute updates" via email
Transurethral Vapor Resection of Prostate—An Alternative Treatment for Benign Prostatic Hyperplasia >100 g
Journal of Endourology, 10/23/09
The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons
BJU International, 11/04/09
Are Sexual Problems More Common in Men who have had a Vasectomy? A Population-Based Study of Australian Men
The Journal of Sexual Medicine, 11/04/09
Article Search
Sponsor


See Latest Articles


